Arix Bioscience (LSE:ARIX) Quick Ratio : 73.10 (As of Jun. 2023)

Arix Bioscience Quick Ratio Chart

Arix Bioscience Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Quick Ratio	Get a 7-Day Free Trial								75.64	85.04	119.40	65.00	73.10

Competitive Comparison of Arix Bioscience's Quick Ratio

For the Biotechnology subindustry, Arix Bioscience's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arix Bioscience's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arix Bioscience's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Arix Bioscience's Quick Ratio falls into.

Arix Bioscience Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Arix Bioscience's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Arix Bioscience's Quick Ratio for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arix Bioscience  (LSE:ARIX) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Arix Bioscience Quick Ratio Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Arix Bioscience (LSE:ARIX) Business Description